Skip to main content
Clinical Trials/CTRI/2020/04/024876
CTRI/2020/04/024876
Not yet recruiting
Phase 2

A Comparative Pharmaceutico-Analytical and Clinical study of Mritasanjeevana Rasa and its modified formulation on Amavata (Rheumatoid Arthritis)

ational Institute of Ayurveda Jaipur0 sites0 target enrollmentStarted: TBDLast updated:

Overview

Phase
Phase 2
Status
Not yet recruiting
Sponsor
ational Institute of Ayurveda Jaipur

Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • Patients present with classical signs \& symptoms of Amavata.
  • Patients willing to give informed consent to participate for 28 days.

Exclusion Criteria

  • Patients present with systemic diseases like Diabetes mellitus, Cardiac Disease, Hypertension, etc.
  • Patients on prolonged ( \> 6 weeks) medication with corticosteroids, etc. or any other drugs that may have an impact on the outcome of the study
  • Pregnant/lactating mother

Investigators

Sponsor
ational Institute of Ayurveda Jaipur

Similar Trials